Sinusoidal Obstruction Syndrome Clinical Trial
Official title:
A Retrospective Study About Detection of Sinusoidal Obstruction Syndrome With Ultrasound After Allogeneic Hematopoietic Stem Cell Transplantation
Verified date | November 2019 |
Source | Central Hospital, Nancy, France |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
We would like conduct a retrospective study in our center to evaluate the early detection of sinusoidal obstruction syndrome with hepatic ultrasound after allogeneic hematopoietic stem cell transplantation.
Status | Completed |
Enrollment | 114 |
Est. completion date | September 2018 |
Est. primary completion date | September 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - all adult patients with allogeneic hematopoietic stem cell transplantation in Nancy University Hospital between Sep 2016 and Sep 2018 Exclusion Criteria: - age < 18 years old |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Central Hospital, Nancy, France |
Lassau N, Auperin A, Leclere J, Bennaceur A, Valteau-Couanet D, Hartmann O. Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease. Transplantation. 2002 Jul 15;74(1):60-6. — View Citation
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | incidence in the cohort of sinusoidal obstruction syndrome | incidence | up to 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03858530 -
Ultrasound Elastography to Predict Development of SOS
|
Phase 4 | |
Recruiting |
NCT05987124 -
Defibrotide Dose-escalation for SOS Post-HSCT
|
Phase 2 | |
Recruiting |
NCT04313036 -
5-day Defibrotide Treatment for Hepatic SOS/VOD
|
Phase 2 | |
Completed |
NCT00885950 -
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
|
N/A | |
Completed |
NCT02483481 -
Using Ultrasound Elastography to Predict Development of SOS
|
N/A | |
Not yet recruiting |
NCT06258525 -
SAMe in Prevention of Oxaliplatin-associated Liver Injury
|
Phase 2 | |
Recruiting |
NCT06054451 -
Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India
|
||
Completed |
NCT03426358 -
Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)
|
N/A | |
Withdrawn |
NCT03963999 -
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
|
Phase 4 | |
Recruiting |
NCT03865589 -
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
|
N/A | |
Completed |
NCT03132337 -
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
|